Get started
Bullish Elliot Wave count on AEDThis is my bullish Elliott Wave count for Aedifica, which I consider the more probable scenario. The corrective structure that began in early February 2020 reached the ideal Fibonacci retracement levels for a sharp correction between 0.5 and 0.618 by October 26, 2023 (not shown in this chart), and has already unfolded over nearly four years. Despite the fact that price action over the past year has remained largely corrective and we haven’t yet seen a clear impulsive move, I still view this as the most likely count and my preferred scenario. In my view, the yellow micro-degree Wave 1/2 has completed, and we are currently in the third wave impulse, with the lower orange-degree Wave 1/2 either completed or nearing completion. That said, the recent upward movement still appears somewhat corrective in nature, so we should remain cautious of the potential for a larger correction which I discussed in detail yesterday.
EURONEXT:AEDLong
by UnbieX
Short on DERICHEBOURG (DGB)Over sold daily and weekly RSI state. Major resistance level of 6.5 reached multiple times without breacking. Big red candle and the next day a shooting star candlestick (not sure about this one but it looks like). Currently hooked on the 6.0 major support level. It could go up but I doubt, the seller pressure is truely visible and the resistance at 6.5 was pretty strong. My safe TP target is 5.680 (-5,80%) which is the next major support level.
EURONEXT:DBGShort
by terryMars
1
Sanofi takes a bold step by acquiring Blueprint MedicinesSanofi Makes Bold Move with $9.5 Billion Acquisition of Blueprint Medicines By Ion Jauregui – Analyst at ActivTrades French pharmaceutical giant Sanofi (EPA:SAN) has kicked off 2025 with a bold strategic move: the acquisition of U.S.-based biotech Blueprint Medicines (NASDAQ:BPMC) for up to $9.5 billion. The deal, expected to be the largest healthcare acquisition in Europe this year, includes an upfront payment of $129 per share, plus contingent value rights (CVRs) tied to the commercial success of BLU-808, a treatment for systemic mastocytosis. With this acquisition, Sanofi secures full control of Ayvakit, currently the only approved treatment for this rare disease, thereby strengthening its position in the lucrative rare diseases segment. Strong Financial Momentum in 2024 Sanofi’s latest annual results confirm the company’s solid trajectory. In 2024, the group generated €41.081 billion in revenue, representing a 11.3% increase at constant exchange rates. Adjusted net income reached €8.912 billion, up 4.1%, despite cost pressures in some segments. Flagship drug Dupixent, developed in partnership with Regeneron, brought in €13.072 billion, accounting for nearly a third of total group revenue. The vaccines segment also performed strongly, led by Beyfortus sales, with a growth of 13.5%. Favorable Market: Technical Analysis Sanofi shares have also been enjoying a positive trend. As of yesterday’s close, the stock was trading at €86.77, with a bullish pre-market and not far from its annual high of €106.20. From May to May, the stock gained as much as 47.43% year-over-year, reaching all-time highs. After the announcement of U.S. tariff policies, the stock corrected nearly 21%, but quickly recovered from a key support level at €82.51, now hovering near €87 with a positive outlook. The only technical concern lies in the bearish crossover of moving averages observed earlier this year. Should this acquisition reinforce Sanofi’s fundamentals, the resistance level around €93.70 may soon be breached and potentially become new support. Failure to do so, however, could see a short-term pullback toward €67.78. What’s clear is that the company is committed to maintaining its year-over-year growth trend and pushing for new record highs. Key technical levels: • Support: €79.80 (current point of control and mid-range zone) • Immediate resistance: €106.20 (52-week high) • RSI: 37.45 – signaling an oversold zone, possibly ready for recovery • Moving Averages: Showing a downward trend this quarter, requiring a shift to resume the bullish path From a fundamental perspective, the stock trades at an estimated P/E ratio of 12.7, which still offers value considering its earnings outlook and a solid dividend yield of 3.8%. Share Buyback and Clear Roadmap As part of its shareholder value strategy, Sanofi has launched an ambitious €5 billion share buyback program, equivalent to 4% of its capital. This move reflects management’s confidence in the company’s performance and comes amid strong cash flow generation. For 2025, Sanofi projects mid-to-high single-digit revenue growth and a low double-digit increase in adjusted net income. Conclusion: Innovation, Profitability, and Global Ambition The acquisition of Blueprint Medicines not only marks the largest healthcare deal in Europe this year, but also cements Sanofi’s strategic shift: focusing on innovative treatments, specialized markets, and global expansion. With a solid financial foundation, a technically strong stock, and a more focused product portfolio, Sanofi is emerging as a major player in the healthcare sector for 2025. ******************************************************************************************* The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and such should be considered a marketing communication. All information has been prepared by ActivTrades ("AT"). The information does not contain a record of AT's prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance is not reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk.
EURONEXT:SANLong
by ActivTrades
Wycoff Accumulation Phase?Carrefour is one of the world's largest grocery retailers, think of it as the European Walmart. But the execution of the business by management could not be any different. We are talking about a 90% decline since it's highs in 1999. Failed market expansion, competition from budget retailers like Aldi and Lidl, online retailers have taken market share. This company has suffered and anyone bag holding this must have written this off as a bad nightmare. The chart suggests that we could be back in an accumulation phase. We are sitting at the 25 year trend line resistance, if this is broken and we reclaim the POC, this could set up for a nice counter rally. This chart is more a warning than an investment idea. Don't get caught out holding bags, especially not in retail names with weak moat and intense competition.
EURONEXT:CA
by NoFOMO_
8
Ryanair Takes Off Strong Despite TurbulenceBy Ion Jauregui – Analyst, ActivTrades Ryanair (ISE: RYA) closed its 2024/25 fiscal year with results that—despite some headwinds—demonstrate the resilience of its ultra-low-cost model. The Irish carrier posted a 4 % increase in revenues to €13,950 m, up from €13,444 m in 2023, while net profit fell 16 % to €1,610 m, penalized by fares that were 7 % lower and disputes with online travel agencies that impacted ticket sales. Despite the drop in profitability, Ryanair carried a record 200.2 million passengers over the past year—9 % more than the previous period—and has revised its guidance to 206 million passengers in 2026 thanks to a rebound in fares and summer bookings, which are already 1 % ahead of last season. Key Financial Data • 2024 (year ended 31 Mar 2024): o Revenues: €13,444 m o Net profit: €1,920 m o Passengers carried: 200.2 m (+9 % YoY) • 2025 (year ended 31 Mar 2025): o Revenues: €13,950 m (+4 % YoY) o Net profit: €1,610 m (–16 % YoY) Analysis As of the close on 20 May 2025, Ryanair’s share price stood at €23.70, having traded in a YTD range of €19.59–21.75—about a 23.5 % gain since January. On 2 May this range was breached, and the stock reached a high of €24.23 yesterday. That level corresponds roughly to the 23.8 % Fibonacci retracement, suggesting the price may struggle to exceed €25 without first establishing a new support level to underpin further gains. The current upside potential from today’s levels is around 3 %, and the consensus rating is “Outperform.” Moving-average crossovers support this bullish thesis: on 29 April, the 50-day MA crossed above the 100-day MA, confirming a strong uptrend and signaling stability. Additionally, the “bell signal” is robust within the trading range, reinforcing the case for a partial pullback toward the top of the range before the next leg up. Outlook With summer bookings and fares starting the season strongly, Ryanair plans to bolster its shareholders’ returns via a €750 m share buyback program and a €400 m special dividend, while optimizing its fleet in anticipation of potential delays to the 737 MAX 8 deliveries in Europe. The carrier believes that moderating fuel costs and strong underlying demand will support profitability in the 2025/26 fiscal year. Conclusion Ryanair once again underscores the strength of its ultra-low-cost model: it carried a record number of passengers, adjusted fares upward, and raised its traffic guidance—all despite margin pressure. With a solid stock performance (YTD gain near 24 %) and an analyst consensus rating of “Outperform,” the airline heads into summer with confidence. The €750 m buyback and €400 m special dividend reinforce its shareholder commitment, while lower fuel costs and efficient management of the 737 MAX fleet underpin expectations for a rebound in profits in 2025/26. In short, Ryanair is catching a favorable tailwind that could lift both its results—and its share price—to new highs by 2026. ******************************************************************************************* The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and such should be considered a marketing communication. All information has been prepared by ActivTrades ("AT"). The information does not contain a record of AT's prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance is not reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk.
EURONEXT:RYALong
by ActivTrades
Eden still Red - but not for longLooking outside the crowded US tech space and more at longer term value compounders, Edenred ticks a lot of boxes and is worth both a fundamental and technical analysis. Edenred represents a compelling opportunity for long term investors seeking exposure to the growing intersection of fintech, digital payments, and employee benefits. With a strong foothold in over 45 countries and a user base spanning over 60 million individuals, Edenred’s business model is rooted in high-margin, recurring revenues through solutions like meal vouchers, mobility cards, and digital corporate payments. Over the past three years, Edenred has delivered consistent double-digit revenue growth — up ~18% in 2022, 25% in 2023, and 17% in 2024 — signaling both strong execution and a robust underlying demand for its digital-first platform. A conservative DCF model, based on a 12% revenue CAGR over the next five years, 25% free cash flow margins, an 8% discount rate, and a 2.5% terminal growth rate, yields an intrinsic value of ~€65 per share, well above its current market price of €27, offering an attractive 58% upside. This disconnect between Edenred’s fundamentals and its valuation is striking, especially given its inclusion in the CAC 40 index and exposure to secular tailwinds in digital transformation, remote work, and ESG-aligned employee welfare programs. The TA of the chart doesn’t look great, the stock hasn’t recovered since the 2022 sell off. Yet the company continues to grow revenue and offers a highly attractive dividend yield. We are getting bullish divergences on the RSI and we are sitting at previous all time high resistance which appears to be support. The 5 wave move down may be over and should the US tech space sell off, I would expect money to flow into Europe and the safer dividend plays. I’m keeping an eye on this, not financial advice.
EURONEXT:EDENLong
by NoFOMO_
TTE: Ready for a correction if the brent suffers from macro Correlation with Oil Prices: TTE, being an oil and gas company, is closely correlated with WTI and Brent crude oil prices. Market Uncertainty: The fundamentals of industrial production are uncertain due to high commercial tariffs and evolving economic conditions, which could impact demand and slow down industrial activities. OPEC+ Production: OPEC+ countries are expected to increase production more than anticipated, potentially leading to a slight correction in oil prices . Financial Strategies: TTE has buyback plans and other financial revenues, which could provide some stability 3 4. Stock Price Prediction: If oil prices range between €50 and €65 per barrel, TTE's stock might vary between €42 and €55. From a technical standpoint, breaking the €52 level on a weekly timeframe could lead to a correction down to €42. Conversely, stable fluctuation above €52 could keep the stock in a fluctuating mode, potentially rising to €60. Let's keep an eye on how things evolve! If you found this analysis helpful, please like and boost 😊
EURONEXT:TTEShort
by Moji_FB
Renault’s €2.2 BILLION Loss SHOCKER: Nissan’s Costs Hit Hard!Renault’s €2.2 BILLION Loss SHOCKER 💥: Nissan’s Turnaround Costs Hit Hard! 🚗💸 Imagine Renault and Nissan are like best friends 🤝 who share a big toy car company 🏎️. Renault owns a big piece of Nissan, kind of like having a lot of the toy car's parts 🛠️. But Nissan had a tough year because fewer people bought their cars 📉, especially in places like China 🇨🇳. To fix this, Nissan is making some big changes, like making fewer cars 🚘 and saying goodbye to some workers 👋. These changes cost a lot of money 💰, and because Renault owns part of Nissan, Renault has to share the cost 😓. This means Renault will lose some money this year, about 2.2 billion euros 💶, which is like losing a giant pile of coins! 🪙 But Renault's bosses think these changes will help Nissan make better cars and sell more in the future 🌟, so both friends can be strong again 💪. Analysis (Up to May 13, 2025): Renault Group’s announcement of a €2.2 billion hit to its first-quarter earnings 📊 stemming from its 35.71% stake in Nissan reflects the interconnected financial dynamics of their strategic alliance 🤝, as well as broader challenges in the global automotive industry 🌍. Below is an institutional-level analysis of the situation, incorporating the provided data and contextualizing it within the current market environment as of May 13, 2025 🕑. 1. Financial Impact and Impairment Context 📉 Renault’s Exposure to Nissan: Renault’s €2.2 billion earnings hit 💥 is directly tied to Nissan’s reported net loss of approximately $5 billion 📅 for the fiscal year ending March 2025. This loss includes impairments (writing down the value of assets like factories 🏭 or inventory 📦 that are no longer worth as much) and restructuring costs (expenses for layoffs 👥 and factory reductions 🔽). As a 35.71% shareholder, Renault absorbs a proportional share of Nissan’s financial setbacks 📉, which are booked as a negative contribution to Renault’s earnings 💸. Accounting Implications: The impairments reflect Nissan’s need to adjust the book value of its assets 📜 to align with weaker market performance 📊, particularly in China 🇨🇳, where sales have significantly declined 📉. Restructuring costs are linked to Nissan’s November 2024 announcement of cutting 9,000 jobs 🚫 and reducing global production capacity by 20% 🔧. These measures aim to streamline operations but involve upfront costs 💰, impacting Renault’s financials due to equity accounting rules for its Nissan stake 📈. Market Reaction: Despite the earnings hit, Renault’s shares rose 1.2% to €48.46 in early trading on the announcement day 📈, suggesting investor confidence in the long-term benefits of Nissan’s turnaround plan 🌟 or optimism about Renault’s core operations 🚗. This resilience may also reflect broader market dynamics, such as stabilizing demand in Europe 🇪🇺 or positive sentiment toward Renault’s electrification strategy ⚡. 2. Nissan’s Turnaround Plan and Strategic Rationale 🔄 Sales Decline: Nissan’s fiscal 2025 sales fell 4.3% to 3.3 million units 📉, driven by weakness in China 🇨🇳, Japan 🇯🇵, and Europe 🇪🇺. China, the world’s largest auto market 🌐, has been a pain point for many global automakers due to intense competition from domestic brands like BYD 🚘 and declining demand for traditional vehicles amid an economic slowdown 📉. Restructuring Efforts: Nissan’s turnaround plan, announced on April 24, 2025 📅, focuses on cost reduction 💸 and operational efficiency 🔧. The 9,000 job cuts 🚫 and 20% reduction in production capacity 🔽 signal a shift toward leaner operations, prioritizing high-margin markets and products 📈. This aligns with industry trends, as automakers globally face pressure to adapt to lower demand for internal combustion engine vehicles 🚗 and invest heavily in electric vehicles (EVs) ⚡. China Strategy: Nissan’s weak performance in China 🇨🇳 underscores the need for a revised market approach 🔄, potentially involving localized EV models ⚡ or partnerships to compete with dominant players 🏆. The impairments likely include devaluing assets tied to underperforming Chinese operations, such as factories 🏭 or unsold inventory 📦. 3. Renault-Nissan Alliance Dynamics 🤝 Historical Context: The Renault-Nissan-Mitsubishi Alliance, formed in 1999 🗓️, has been a cornerstone of both companies’ global strategies 🌍, enabling shared R&D 🧠, platforms, and cost efficiencies 💰. Renault’s significant stake in Nissan ties their financial fates closely 💸, but recent years have seen tensions 😬, including governance issues and strategic divergences, particularly after the 2018 Carlos Ghosn scandal 🚨. Mutual Dependence: While Nissan’s challenges weigh on Renault ⚖️, the alliance remains critical for both. Renault benefits from Nissan’s scale in markets like North America 🇺🇸 and Asia 🌏, while Nissan leverages Renault’s expertise in Europe 🇪🇺 and EV technology ⚡ (e.g., Renault’s success with models like the Megane E-Tech 🚗). The €2.2 billion hit 💥 underscores the risks of this interdependence but also highlights Renault’s commitment to supporting Nissan’s recovery 🌟, likely viewing it as essential for the alliance’s long-term viability 📅. Potential Risks: If Nissan’s turnaround falters 🚫, Renault could face further financial strain 😓, including additional impairments 📉 or pressure to dilute its stake. Conversely, a successful restructuring could strengthen the alliance 💪, boosting shared EV development ⚡ and cost synergies 💸. 4. Industry and Macro Context (Up to May 13, 2025) 🌍 Global Auto Industry: The automotive sector faces a complex transition in 2025 🔄, balancing the shift to EVs ⚡, supply chain disruptions 🚚, and regional demand variations 📊. European automakers like Renault are under pressure to meet stringent EU emissions targets 🌿, while Japanese firms like Nissan grapple with declining relevance in markets like China 🇨🇳, where EV adoption is accelerating ⚡. China’s Role: China’s market challenges are systemic 🌐, with global automakers losing share to local brands 🚗. Nissan’s sales drop 📉 reflects this trend, and Renault’s indirect exposure via Nissan amplifies its vulnerability to China’s slowdown 😓. EV Transition: Both Renault and Nissan are investing in electrification ⚡, but Nissan’s restructuring may delay its EV rollout 📅, potentially ceding ground to competitors 🏆. Renault, with its stronger EV portfolio in Europe 🇪🇺, may need to lead alliance efforts in this area 🚗. Macro Factors: Rising interest rates 📈, inflation 📊, and geopolitical uncertainties 🌍 (e.g., trade tensions) continue to impact consumer demand and production costs 💰. These factors likely exacerbate Nissan’s sales declines 📉 and Renault’s financial hit 💸. 5. Long-Term Outlook (4-10 Year Horizon) 🔮 Nissan’s Recovery Potential: If Nissan’s restructuring succeeds ✅, it could emerge leaner and more competitive by 2029 📅, with a focus on high-growth segments like EVs ⚡ and markets like North America 🇺🇸. This would benefit Renault through improved equity income and alliance synergies 🤝. Renault’s Strategy: Renault is likely to prioritize its European operations 🇪🇺 and EV leadership ⚡ while supporting Nissan’s recovery 🌟. Divesting its Nissan stake seems unlikely in the near term 🚫, given the strategic importance of the alliance, but Renault may seek to diversify its portfolio to mitigate risks 🛡️. Alliance Evolution: Over the next 4-10 years 📅, the Renault-Nissan-Mitsubishi Alliance could deepen integration in EV platforms ⚡ and autonomous driving 🤖 or face pressure to restructure if financial strains persist 😓. External partnerships (e.g., with Chinese firms for Nissan 🇨🇳) or mergers could reshape the alliance’s structure 🔄. Risks to Monitor: Key risks include prolonged weakness in China 🇨🇳, failure to execute EV strategies 🚫, and macroeconomic volatility 🌍. Regulatory changes, such as stricter emissions rules 🌿 or trade barriers 🚧, could further complicate the alliance’s plans 📜. Conclusion 🎯 Renault’s €2.2 billion earnings hit 💥 reflects the immediate financial burden of Nissan’s restructuring and market challenges, particularly in China 🇨🇳. However, the institutional perspective sees this as a strategic investment in Nissan’s long-term recovery 🌟, critical for the Renault-Nissan-Mitsubishi Alliance’s competitiveness in a rapidly evolving industry 🚗. For a 4 to 10 year old, it’s like Renault helping a struggling friend fix their toy car 🛠️, taking a short-term loss 💸 to ensure both can play better in the future 🎉. Over the next 4-10 years 📅, the success of Nissan’s turnaround and the alliance’s ability to navigate the EV transition ⚡ will determine whether this hit becomes a stepping stone 🪜 or a recurring burden ⚖️.
EURONEXT:RNOLong
by DCAChampion
Strategic Toast for Diageo and Pernod Ricard in IndiaIon Jauregui – Analyst ActivTrades The recent trade agreement between the United Kingdom and India has delivered a game-changing moment for major alcoholic beverage companies, particularly those with significant exposure to Scotch whisky. The reduction of import tariffs from 150% to 75% opens the door to substantial expansion in one of the world’s most promising markets: India. Solid Economic Fundamentals For Diageo (LSE: DGE) , the global leader in premium alcoholic beverages and parent company of iconic brands like Johnnie Walker, Tanqueray, and Guinness, the news could not have come at a better time. India already represents its largest market by volume, with sales reaching $1.3 billion in 2024—6% of total revenue. The ability to offer premium products at more competitive prices could further solidify its position in the Asian market and significantly boost margins. Diageo generates more than £17 billion in annual revenue, with operating margins close to 30%. Its business model is built around premiumization and brand strength, allowing it to maintain consistent profitability and a stable dividend policy. However, the company has recently faced challenges such as slowing consumption in the U.S. and volatility in emerging markets. Pernod Ricard (EPA: RI) , Diageo’s direct competitor, also stands to benefit from the agreement. The French company, owner of brands such as Chivas Regal, Jameson, and Absolut, holds approximately 30% of the Scotch whisky market share in India. According to Goldman Sachs estimates, the tariff cut could translate into a multi-percentage-point increase in earnings per share, at a time when the sector is grappling with falling demand and inventory surpluses. From a financial perspective, both companies show solid fundamentals, though with specific challenges. Pernod Ricard closed its last fiscal year with sales exceeding €12 billion and operating margins above 25%. Its strategy has focused on reinforcing the positioning of high-end brands through sustained investment in marketing and local distribution, especially in Asia. Still, excess stock and changing consumption patterns in Europe have limited its recent performance. Technical Analysis Diageo has undergone corrections from its 2022 highs of £3,763 to lows of £1,807 in April this year. The stock has since rebounded to £2,179. The daily chart shows the point of control around £2,307—slightly above the current price. Moving average crossovers suggest a potential corrective upward trend that has not yet materialized. The RSI stands at 63.89%, indicating overbought conditions, suggesting that an upward trend may emerge in the coming weeks. Pernod Ricard, by contrast, has been in a downward trend since 2023, seemingly finding support at €83.04, also in April this year—coinciding with 2016 price levels. The current point of control is around €106. Moving averages appear to indicate a shift in direction to the upside. If conditions improve, we could see a potential move toward €120. Opportunity and Competition The trade agreement offers both companies a clear tactical advantage, though not without challenges. Despite the national tariff reduction, state-level taxes within India remain a significant operational barrier. Moreover, winning over the Indian consumer will depend not only on price, but also on the ability to connect with cultural preferences and deliver differentiated brand propositions. In an environment where major economies are seeking to diversify and strengthen trade ties, this agreement could mark the beginning of a new era for the premium alcoholic beverages sector. For Diageo and Pernod Ricard, it’s a moment to raise a glass—but with a firm focus on strategy. ******************************************************************************************* The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and such should be considered a marketing communication. All information has been prepared by ActivTrades ("AT"). The information does not contain a record of AT's prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance is not reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk.
EURONEXT:RILong
by ActivTrades
ABI Showing Bullish Signs Above EMA 209 – Potential Breakout ABI Showing Bullish Signs Above EMA 200 – Potential Breakout Ahead Anheuser-Busch InBev (ABI) experienced a significant drop in 2021, marked by a large-volume bearish candle. Since then, the stock has been gradually recovering and is now trading above the EMA 200, indicating a potential shift in trend. Key observations: Price above EMA 209: Suggests a bullish long-term trend. Gradual recovery: Indicates steady accumulation. Potential breakout: A move above recent resistance levels could confirm a bullish breakout. Monitoring for a sustained move above resistance with increased volume could provide a strong bullish signal. Not financial advice – just my technical analysis. #ABI #AnheuserBusch #StockAnalysis #EMA200 #BullishTrend #TechnicalAnalysis #TradingView
EURONEXT:ABI
by abdeljalillariam
Is Europe's Decline Grounding Airbus's Ascent?Europe's economic situation presents a complex picture of modest growth juxtaposed with significant challenges, creating uncertainty for major players like Airbus. In 2024, the European Union's GDP growth was projected to be below 1%, with only a slight acceleration anticipated for 2025. This sluggish economic expansion, when coupled with persistent inflation and ongoing geopolitical tensions, lays an unstable foundation for sustained economic prosperity. The cohesion of the European Union itself is increasingly in question, influenced by the rise of nationalist sentiments and the potential for increased trade protectionism. The EU faces structural challenges, including economic disparities, political divisions, and growing Euroscepticism, which could precipitate its disintegration. Should this occur, individual countries would be forced to navigate complex economic and geopolitical landscapes independently, generating significant implications for multinational corporations like Airbus. Concurrently, Airbus is navigating a highly competitive environment, most notably with its enduring rivalry with Boeing, which is actively seeking to overcome its recent operational and reputational hurdles. While Airbus has recently secured a larger market share, Boeing's inherent resilience, combined with the potential entry of new competitors, may challenge Airbus's current market dominance. To sustain its competitive edge, Airbus must not only effectively manage the economic uncertainties and potential fragmentation within Europe but also maintain its commitment to technological innovation and efficient production. The company's ability to nimbly adapt to these multifaceted challenges will be crucial in determining its long-term success and continued leadership in the global aerospace industry.
EURONEXT:AIRShort
by UDIS_View
Christian Dior Stock Chart Fibonacci Analysis 042825Trading Idea 1) Find a FIBO slingshot 2) Check FIBO 61.80% level 3) Entry Point > 450/61.80% Chart time frame:D A) 15 min(1W-3M) B) 1 hr(3M-6M) C) 4 hr(6M-1year) D) 1 day(1-3years) Stock progress: C A) Keep rising over 61.80% resistance B) 61.80% resistance C) 61.80% support D) Hit the bottom E) Hit the top Stocks rise as they rise from support and fall from resistance. Our goal is to find a low support point and enter. It can be referred to as buying at the pullback point. The pullback point can be found with a Fibonacci extension of 61.80%. This is a step to find entry level. 1) Find a triangle (Fibonacci Speed Fan Line) that connects the high (resistance) and low (support) points of the stock in progress, where it is continuously expressed as a Slingshot, 2) and create a Fibonacci extension level for the first rising wave from the start point of slingshot pattern. When the current price goes over 61.80% level , that can be a good entry point, especially if the SMA 100 and 200 curves are gathered together at 61.80%, it is a very good entry point. As a great help, tradingview provides these Fibonacci speed fan lines and extension levels with ease. So if you use the Fibonacci fan line, the extension level, and the SMA 100/200 curve well, you can find an entry point for the stock market. At least you have to enter at this low point to avoid trading failure, and if you are skilled at entering this low point, with fibonacci6180 technique, your reading skill to chart will be greatly improved. If you want to do day trading, please set the time frame to 5 minutes or 15 minutes, and you will see many of the low point of rising stocks. If want to prefer long term range trading, you can set the time frame to 1 hr or 1 day.
EURONEXT:CDI
by fibonacci6180